Adiponectin in renal disease: Relationship to phenotype and genetic variation in the gene encoding adiponectin

Kidney International

Volumn 65, Issue 1, 2004, Pages 274-281

  Stenvinkel, Peter ^a   Marchlewska, Alicia ^b   Pecoits Filho, Roberto ^b   Heimbürger, Olof ^b   Zhang, Zhengzhong ^b   Hoff, Catherine ^b   Holmes, Cliff ^b   Axelsson, Jonas ^b   Arvidsson, Sivonne ^b   Schalling, Martin ^b   Barany, Peter ^b   Lindholm, Bengt ^b   Nordfors, Louise ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Adiponectin; Body fat mass; Diabetes mellitus; End stage renal disease; Inflammation; Single nucleotide polymorphism

Indexed keywords

ADIPONECTIN; ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; TRIACYLGLYCEROL;

ADIPONECTIN BLOOD LEVEL; ADIPONECTIN GENE; ADULT; APM1 GENE; ARTICLE; BODY COMPOSITION; BODY FAT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; OBESITY; PHENOTYPIC VARIATION; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0346101485     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00370.x     Document Type: Article

References (34)

1. FOLEY RN, PARFREY PS, SARNAK MJ: Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis 32(Suppl 5):S112-S119, 1998
2. STENVINKEL P, PECOITS-FILHO R, LINDHOLM B: Coronary artery disease in end-stage renal disease - No longer a simple plumbing problem. J Am Soc Nephrol 14:1927-1939, 2003
3. WIECEK A, KOKOT F, CHUDEK J, ADAMCZAK M: Adipose tissue - A novel endocrine organ of interest for the nephrologist. Nephrol Dial Transpl 17:191-195, 2002
4. YAMAUCHI T, KAMON J, WAKI H, et al: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:887-888, 2001
5. ZOCCALI F, MALLAMACI F, TRIPEPI G, et al: Adiponectin, metabolic risk factors, and cardiovascular events among patients with endstage renal disease. J Am Soc Nephrol 13:134-141, 2002
6. OUCHI N, KIHARA S, ARITA Y, et al: Novel modulator for endothelial adhesion molecules. Adipocyte-derived plasma protein adiponectin. Circulation 100:2473-2476, 1999
7. DÍEZ JJ, IGLESIAS P: The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Clin Endocrin 148:293-300, 2003
8. OUCHI N, KIHARA S, ARITA Y, et al: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 102:1296-1301, 2000
9. YAMAUCHI T, KAMON J, ITO Y, et al: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769, 2003
10. MATSUBARA M, MARUOKA S, KATAYOSE S: Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrin & Metab 87:2764-2769, 2002
11. KAZUMI T, KAWAGUCHI A, SAKAI K, et al: Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 25:971-976, 2002
12. ADAMCZAK M, WIECEK A, FUNAHASHI T, et al: Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 16:72-75, 2003
13. HOTTA K, FUNAHASHI T, ARITA Y, et al: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595-1599, 2000
14. ARITA Y, KIHARA S, OUCHI N, et al: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Comm 257:79-83, 1999
15. KUMADA M, KIHARA S, SUMITSUJI S, et al: Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23:85-89, 2003
16. ESPOSITO K, PONTILLO A, DI PALO C, et al: Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: A randomized trial. JAMA 9:1799-1804, 2003
17. MAEDA N, TAKAHASHI M, FUNAHASHI T, et al: PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50:2094-2099, 2001
18. STENVINKEL P, HEIMBÜRGER O, PAULTRE F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
19. VASSEUR F, HELBECQUE N, DINA C, et al: Single-nucleotide polymorphism haplotypes in both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11:2607-2614, 2002
20. NORDFORS L, JANSSON M, SANDBERG G, et al: Large-scale genotyping of single nucleotide polymorphisms by Pyrosequencing trade mark and validation against the 5′nuclease (Taqman®) assay. Hum Mutat 19:395-401, 2002
21. ARNER P: The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 14:137-145, 2003
22. CNOP M, HAVEL PJ, UTZSCHNEIDER KM, et al: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex. Diabetologia 46:459-69, 2003
23. ATZMON G, YANG XM, MUZUMDAR R, et al: Differential gene expression between visceral and subcutaneous fat depots. Horm Metab Res 34:622-628, 2002
24. IMAGAWA A, FUNAHASHI T, NAKAMURA T, et al: Elevated serum concentration of adipose-derived factor, adiponectin in patients with type 1 diabetes. Diabetes Care 25:1665-1666, 2002
25. ZOCCALI C, MALLAMACI F, PANUCCIO V, et al: Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int 63(Suppl 84):S98-S102, 2003
26. FASSHAUER M, KLEIN J, NEUMANN S, et al: Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Comm 290:1084-1089, 2002
27. BERG AH, COMBS TP, DU X, et al: The adipocyte-secreted protein Acrp 30 enhances hepatic insulin action. Nat Med 7:947-953, 2001
28. OUCHI N, KIHARA S, FUNAHASHI T, et al: Reciprocal association of C-reative protein with adiponectin in blood stream and adipose tissue. Circulation 107:671-674, 2003
29. ENGELI S, FELDPAUSCH M, GORZELNIAK K, et al: Association between adiponectin and mediators of inflammation in obese women. Diabetes 52:942-947, 2003
30. FERNANDEZ-REAL JM, LOPEZ-BERMEJO A, CASAMITJANA R, RICART W: Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Clin Endocrin & Metab 88:2714-2718, 2003
31. OUCHI N, KIHARA S, ARITA Y, et al: Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103:1057-1063, 2001
32. MATSUDA M, SHIMOMURA I, SATA M, et al: Role of adiponectin in preventing vascular stenosis. J Biol Chem 277:37487-37491, 2002
33. OKAMOTO Y, KIHARA S, OUCHI N, et al: Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106:2767-2770, 2002
34. MENZAGHI C, ERCOLINO T, DI PAOLA R, et al: A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51:2306-2312, 2002